CLINICAL_TRIALS
trial_result
· 2017-06-12
Clinical Trial Update: Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse [Phase 2]
Summary
Phase 2 trial evaluated galantamine as an adjunct to cognitive behavioral therapy for cocaine dependence. Results from the completed study have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Cocaine Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-06-12